ADAGEN Side Effects

6920009-3 | Lymphoma
on Jul 28, 2010 Female patient from FRANCE , child 3 years of age, weighting 8.38 lb, was diagnosed with combined immunodeficiency and was treated with Adagen (View Usage). Patient experienced the following unwanted or unexpected effects: lymphoma (What is lymphoma?). Adagen dosage: Se Image. During the same period patient was treated with IMMU G (View Immu-g Review and Immu-g Label ), ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ).

6738948-5 | Pneumonia Parainfluenzae Viral, Respiratory Distress
Patient was taking Adagen (View Usage). Patient had the following side effects: pneumonia parainfluenzae viral, respiratory distress on May 13, 2010 from UNITED STATES Additional patient health information: Female patient , child 7 years of age, was diagnosed with combined immunodeficiency and. Adagen dosage: 375 Iu;biw;im.

6700174-3 | Lymphoma
Adverse event was reported on Apr 19, 2010 by a Female patient taking Adagen (View Usage) (Dosage: 15 Iu/kg;biw;im; 60 Iu/kg;biw;im; 26 Iu/kg;biw;im) was diagnosed with combined immunodeficiency and. Location: FRANCE , child 3 years of age, weighting 8.38 lb, After Adagen was administered, patient had the following side effects: lymphoma (What is lymphoma?). During the same period patient was treated with IMMU G (View Immu-g Review and Immu-g Label ), ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ).

6648915-8 |
on Mar 09, 2010 Female patient from FRANCE , child 3 years of age, weighting 8.38 lb, was diagnosed with combined immunodeficiency and was treated with Adagen (View Usage). . Adagen dosage: 15 Iu/kg;biw;im, 60 Iu/kg;biw;im, 26 Iu/kg;biw;im, 60 Iu/kg;biw;im.


6157809-6 | Convulsion, Encephalopathy, Respiratory Failure
on Apr 01, 2009 Female patient from FRANCE , weighting 7.05 lb, was treated with Adagen (View Usage). Patient had the following side effects: convulsion, encephalopathy, respiratory failure. Adagen dosage: Im. Patient was hospitalized.

6112008-9 | Anaemia Haemolytic Autoimmune, Coombs Test Positive, Epilepsy
Patient was taking Adagen (View Usage). After Adagen was administered, patient had the following side effects: anaemia haemolytic autoimmune, coombs test positive, epilepsy (What is epilepsy?) on Feb 25, 2009 from ITALY Additional patient health information: Male patient , weighting 22.05 lb, was diagnosed with combined immunodeficiency and. Adagen dosage: 60 Iu/kg;biw;im; 30 Iu/kg;biw;im; 31 Iu/kg;biw;im; 27 Iu/kg;biw;im; 25 Iu/kg;biw;im. During the same period patient was treated with AMPHOTERICIN B (View Amphotericin B Review and Amphotericin B Label ), IMMUNOGLOBULINS (View Immunoglobulins Review and Immunoglobulins Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), COTRIMOXAZOLE (View Cotrimoxazole Review and Cotrimoxazole Label ). Patient was hospitalized and became disabled.

5909596-1 | Brain Abscess, Convulsion, Lung Abscess, Meningitis Haemophilus, Pneumonia, Respiratory Failure
Adverse event was reported on Sep 26, 2008 by a Male patient taking Adagen (View Usage) (Dosage: 0.75 Ml;biw;sc) was diagnosed with combined immunodeficiency and. Location: UNITED STATES , child 2 years of age, weighting 22.05 lb, Patient experienced the following unwanted or unexpected effects: brain abscess, convulsion, lung abscess, meningitis haemophilus, pneumonia (What is pneumonia?), respiratory failure. During the same period patient was treated with ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ). Patient was hospitalized and became disabled.

5903361-7 | Pneumonia
on Sep 22, 2008 Female patient from UNITED STATES , child 2 years of age, was treated with Adagen (View Usage). Patient had the following side effects: pneumonia (What is pneumonia?). Adagen dosage: . Patient was hospitalized.

5877371-2 | Cholangitis Sclerosing, Diarrhoea, Liver Function Test Abnormal
on Aug 25, 2008 Male patient from COLOMBIA , child 4 years of age, was diagnosed with adenosine deaminase deficiency, combined immunodeficiency and was treated with Adagen (View Usage). After Adagen was administered, patient had the following side effects: cholangitis sclerosing, diarrhoea, liver function test abnormal. Adagen dosage: . Patient was hospitalized.

5875744-5 | Cholangitis Sclerosing, Diarrhoea, Liver Function Test Abnormal
Patient was taking Adagen (View Usage). Patient experienced the following unwanted or unexpected effects: cholangitis sclerosing, diarrhoea, liver function test abnormal on Aug 25, 2008 from COLOMBIA Additional patient health information: Male patient , child 4 years of age, was diagnosed with adenosine deaminase deficiency, combined immunodeficiency and. Adagen dosage: . Patient was hospitalized.

5635802-7 | Blood Alkaline Phosphatase Increased, Cholangitis Sclerosing, Diarrhoea, Gamma-glutamyltransferase Increased, Liver Function Test Abnormal, Transaminases Increased
Adverse event was reported on Feb 13, 2008 by a Male patient taking Adagen (View Usage) (Dosage: ) was diagnosed with combined immunodeficiency and. Location: COLOMBIA , child 4 years of age, Patient had the following side effects: blood alkaline phosphatase increased, cholangitis sclerosing, diarrhoea, gamma-glutamyltransferase increased, liver function test abnormal, transaminases increased. Patient was hospitalized.

5578546-2 | Lobar Pneumonia, Lymphocyte Count Decreased, Measles, Respiratory Failure
on Dec 20, 2007 Female patient from FRANCE , child 10 years of age, was diagnosed with combined immunodeficiency and was treated with Adagen (View Usage). After Adagen was administered, patient had the following side effects: lobar pneumonia, lymphocyte count decreased, measles (What is measles?), respiratory failure. Adagen dosage: 30 Iu/kg; Biw; Im; 44 Iu/kg; Biw; Im. During the same period patient was treated with TRIMETOPRIM ^NAF^ (View Trimetoprim ^naf^ Review and Trimetoprim ^naf^ Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), NISTATIN (View Nistatin Review and Nistatin Label ).

5574101-9 | Anaemia Haemolytic Autoimmune, Epilepsy, Malaise
on Dec 12, 2007 Male patient from FRANCE , weighting 22.05 lb, was diagnosed with combined immunodeficiency and was treated with Adagen (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia haemolytic autoimmune, epilepsy (What is epilepsy?), malaise. Adagen dosage: 60 Iu/kg; Biw; Im; 30 Iu/kg; Biw; Im 31 Iu/kg; Biw; Im; 27 Iu/kg; Biw; Im; 25 Iu/kg; Biw; Im. During the same period patient was treated with AMPHOTERICIN B (View Amphotericin B Review and Amphotericin B Label ), IMMUNOGLOBULINS (View Immunoglobulins Review and Immunoglobulins Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), COTRIM (View Cotrim Review and Cotrim Label ). Patient was hospitalized.

5383514-X | Arthralgia, Bacterial Infection, Blood Lactate Dehydrogenase Increased, Burkitt's Lymphoma, Cytomegalovirus Infection, Disease Recurrence, Gait Disturbance, Herpes Simplex, Herpes Zoster
Patient was taking Adagen (View Usage). Patient had the following side effects: arthralgia, bacterial infection (What is bacterial infection?), blood lactate dehydrogenase increased, burkitt's lymphoma, cytomegalovirus infection (What is cytomegalovirus infection?), disease recurrence, gait disturbance, herpes simplex (What is herpes simplex?), herpes zoster on Jun 29, 2007 from CANADA Additional patient health information: Female patient , 14 years of age, was diagnosed with combined immunodeficiency and. Adagen dosage: 30 Iu/kg; Biw; Im.

5371544-3 | Laboratory Test Abnormal
Adverse event was reported on Jun 25, 2007 by a Female patient taking Adagen (View Usage) (Dosage: See Cont Page) . Location: UNITED STATES , child 4 years of age, After Adagen was administered, patient had the following side effects: laboratory test abnormal.

5371543-1 | Alpha 1 Foetoprotein Increased, Haemolytic Anaemia, Hepatic Enzyme Increased, Hepatic Mass, Hepatic Neoplasm Malignant, Hepatoblastoma, Thrombocytopenia, Treatment Noncompliance
on Jun 25, 2007 Male patient from UNITED STATES , weighting 28.66 lb, was diagnosed with combined immunodeficiency and was treated with Adagen (View Usage). Patient experienced the following unwanted or unexpected effects: alpha 1 foetoprotein increased, haemolytic anaemia, hepatic enzyme increased, hepatic mass, hepatic neoplasm malignant, hepatoblastoma, thrombocytopenia, treatment noncompliance. Adagen dosage: . Patient was hospitalized.

5347097-2 | Alpha 1 Foetoprotein Increased, Blood Test Abnormal, Haemolytic Anaemia, Hepatic Enzyme Increased, Hepatic Neoplasm Malignant, Hepatoblastoma
on May 21, 2007 Male patient from UNITED STATES , weighting 28.66 lb, was diagnosed with combined immunodeficiency and was treated with Adagen (View Usage). Patient had the following side effects: alpha 1 foetoprotein increased, blood test abnormal, haemolytic anaemia, hepatic enzyme increased, hepatic neoplasm malignant, hepatoblastoma. Adagen dosage: See Image. Patient was hospitalized.

5275271-2 | Adenosine Deaminase Deficiency, Incorrect Dose Administered
Patient was taking Adagen (View Usage). After Adagen was administered, patient had the following side effects: adenosine deaminase deficiency, incorrect dose administered on Mar 22, 2007 from UNITED STATES Additional patient health information: Female patient , child 4 years of age, weighting 24.91 lb, was diagnosed with adenosine deaminase deficiency and. Adagen dosage: 1.2 Ml (300 Iu) 3 Times A Week. During the same period patient was treated with ZYRTEC (View Zyrtec Review and Zyrtec Label ), MOMETASONE CREAM (View Mometasone Cream Review and Mometasone Cream Label ), ZANTAC (View Zantac Review and Zantac Label ), KETOCONAZOLE SHAMPOO (View Ketoconazole Shampoo Review and Ketoconazole Shampoo Label ), GRISEOFULVIN (View Griseofulvin Review and Griseofulvin Label ).

5271864-7 | Pneumocystis Jiroveci Pneumonia
Adverse event was reported on Mar 01, 2007 by a Male patient taking Adagen (View Usage) (Dosage: See Image) was diagnosed with combined immunodeficiency and. Location: FRANCE , weighting 22.05 lb, Patient experienced the following unwanted or unexpected effects: pneumocystis jiroveci pneumonia.

5239155-8 | Pneumocystis Jiroveci Pneumonia
on Jan 29, 2007 Male patient from FRANCE , weighting 22.05 lb, was diagnosed with combined immunodeficiency and was treated with Adagen (View Usage). Patient had the following side effects: pneumocystis jiroveci pneumonia. Adagen dosage: See Image.

5226348-9 | Bronchitis, Immune System Disorder, Inhibiting Antibodies, Sinusitis
on Jan 15, 2007 Female patient from UNITED STATES , 18 years of age, was diagnosed with adenosine deaminase deficiency and was treated with Adagen (View Usage). After Adagen was administered, patient had the following side effects: bronchitis (What is bronchitis?), immune system disorder, inhibiting antibodies, sinusitis (What is sinusitis?). Adagen dosage: 10 Iu/kg; X1; Im, See Image.

5225093-3 | Asthma, Benign Intracranial Hypertension, Blood Immunoglobulin E Increased, Coombs Test Positive, Haemolytic Anaemia, Papilloedema
Patient was taking Adagen (View Usage). Patient experienced the following unwanted or unexpected effects: asthma (What is asthma?), benign intracranial hypertension, blood immunoglobulin e increased, coombs test positive, haemolytic anaemia, papilloedema on Jan 12, 2007 from FRANCE Additional patient health information: Female patient , child 6 years of age, weighting 36.38 lb, was diagnosed with combined immunodeficiency and. Adagen dosage: 30 Iu/kg; Qw; Im; See Image. During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), IMMUNOGLOBULINS (View Immunoglobulins Review and Immunoglobulins Label ), ZOVIRAX (View Zovirax Review and Zovirax Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ).

5219107-4 | Hepatic Neoplasm Malignant
Adverse event was reported on Jan 10, 2007 by a Female patient taking Adagen (View Usage) (Dosage: 625 Iu;biw;im) . Location: UNITED STATES , 13 years of age, weighting 97.00 lb, Patient had the following side effects: hepatic neoplasm malignant.

5188512-7 | Pneumonia
on Dec 04, 2006 Male patient from UNITED STATES , child 7 years of age, was treated with Adagen (View Usage). After Adagen was administered, patient had the following side effects: pneumonia (What is pneumonia?). Adagen dosage: 375 Iu; Biw;. Patient was hospitalized.

5187733-7 | Hepatic Neoplasm Malignant
on Dec 05, 2006 Female patient from UNITED STATES , 13 years of age, was treated with Adagen (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic neoplasm malignant. Adagen dosage: 625 Iu;biw;im.

5171840-9 | Hepatic Neoplasm Malignant
Patient was taking Adagen (View Usage). Patient had the following side effects: hepatic neoplasm malignant on Nov 20, 2006 from UNITED STATES Additional patient health information: Female patient , 13 years of age, . Adagen dosage: 625 Iu; Biw; Im.

5148577-5 | Hepatic Neoplasm Malignant
Adverse event was reported on Oct 26, 2006 by a Female patient taking Adagen (View Usage) (Dosage: ) . Location: UNITED STATES , 13 years of age, After Adagen was administered, patient had the following side effects: hepatic neoplasm malignant.

5025431-0 | Optic Atrophy
on May 31, 2006 Male patient from UNITED STATES , 13 years of age, was diagnosed with enzyme abnormality and was treated with Adagen (View Usage). Patient experienced the following unwanted or unexpected effects: optic atrophy. Adagen dosage: Im.

4995392-9 | Adenovirus Infection, Bone Marrow Transplant, Diarrhoea Infectious
on Apr 25, 2006 Female patient from UNITED STATES , child 9 years of age, was treated with Adagen (View Usage). Patient had the following side effects: adenovirus infection, bone marrow transplant (What is bone marrow transplant?), diarrhoea infectious. Adagen dosage: Im. Patient was hospitalized.

4995390-5 | Central Nervous System Lymphoma, Optic Disc Disorder
Patient was taking Adagen (View Usage). After Adagen was administered, patient had the following side effects: central nervous system lymphoma, optic disc disorder on Apr 25, 2006 from UNITED STATES Additional patient health information: Male patient , 13 years of age, was diagnosed with enzyme abnormality and. Adagen dosage: Im.

4920103-2 | Antibody Test Positive, Blood Immunoglobulin G Increased, Catheter Sepsis, Cytomegalovirus Infection, Disease Recurrence, Viral Infection
Adverse event was reported on Jan 30, 2006 by a Female patient taking Adagen (View Usage) (Dosage: 30 Iu/kg; Biw; Im) was diagnosed with immunodeficiency congenital and. Location: GERMANY , child 2 years of age, Patient experienced the following unwanted or unexpected effects: antibody test positive, blood immunoglobulin g increased, catheter sepsis, cytomegalovirus infection (What is cytomegalovirus infection?), disease recurrence, viral infection (What is viral infection?).

4907222-1 | Asthenia, B-cell Lymphoma, Brain Abscess, Burkitt's Lymphoma, Central Nervous System Lymphoma, Decreased Appetite, Facial Palsy, Gaze Palsy
on Jan 24, 2006 Male patient from UNITED STATES , child 10 years of age, weighting 79.37 lb, was diagnosed with combined immunodeficiency and was treated with Adagen (View Usage). Patient had the following side effects: asthenia, b-cell lymphoma, brain abscess, burkitt's lymphoma, central nervous system lymphoma, decreased appetite, facial palsy, gaze palsy. Adagen dosage: 500 Iu; Qw; Im. During the same period patient was treated with ADDERALL 10 (View Adderall 10 Review and Adderall 10 Label ), CLARINEX (View Clarinex Review and Clarinex Label ), SULFAMETHOXAZOLE (View Sulfamethoxazole Review and Sulfamethoxazole Label ), TRIMETHOPRIM (View Trimethoprim Review and Trimethoprim Label ). Patient was hospitalized and became disabled.

4907033-7 | Adenovirus Infection, Bone Marrow Transplant, Epstein-barr Virus Test Positive, Immunodeficiency, Lung Neoplasm, Multi-organ Failure
on Jan 24, 2006 Female patient from UNITED STATES , child 8 years of age, was diagnosed with enzyme abnormality and was treated with Adagen (View Usage). After Adagen was administered, patient had the following side effects: adenovirus infection, bone marrow transplant (What is bone marrow transplant?), epstein-barr virus test positive, immunodeficiency, lung neoplasm, multi-organ failure. Adagen dosage: 30 Iu/kg; Qw; Im. During the same period patient was treated with IMMUNE GLOBULIN INTRAVENOUS (HUMAN) (View Immune Globulin Intravenous (human) Review and Immune Globulin Intravenous (human) Label ).

4907032-5 | Bone Marrow Transplant, Non-hodgkin's Lymphoma Stage Ii
Patient was taking Adagen (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow transplant (What is bone marrow transplant?), non-hodgkin's lymphoma stage ii on Jan 24, 2006 from UNITED STATES Additional patient health information: Male patient , child 12 years of age, was diagnosed with enzyme abnormality and. Adagen dosage: .

4898319-3 | Adenovirus Infection, Bone Marrow Transplant, Immunodeficiency, Multi-organ Failure
Adverse event was reported on Jan 13, 2006 by a Female patient taking Adagen (View Usage) (Dosage: 30 Iu/kg;qw; Im) was diagnosed with enzyme abnormality and. Location: UNITED STATES , child 8 years of age, Patient had the following side effects: adenovirus infection, bone marrow transplant (What is bone marrow transplant?), immunodeficiency, multi-organ failure. During the same period patient was treated with IMMUNE GLOBULIN INTRAVENOUS (HUMAN) (View Immune Globulin Intravenous (human) Review and Immune Globulin Intravenous (human) Label ).

4897107-1 | Bone Marrow Transplant, Catheter Sepsis, Cytomegalovirus Infection, Viral Infection
on Jan 13, 2006 Female patient from GERMANY , child 2 years of age, was diagnosed with enzyme abnormality and was treated with Adagen (View Usage). After Adagen was administered, patient had the following side effects: bone marrow transplant (What is bone marrow transplant?), catheter sepsis, cytomegalovirus infection (What is cytomegalovirus infection?), viral infection (What is viral infection?). Adagen dosage: 30 Iu/kg; Biw; Im.

4655605-X | Meningitis Cryptococcal, Rash Papular, Skin Ulcer
on Apr 26, 2005 Male patient from , child 7 years of age, weighting 66.14 lb, was diagnosed with enzyme supplementation and was treated with Adagen (View Usage). Patient experienced the following unwanted or unexpected effects: meningitis cryptococcal, rash papular, skin ulcer. Adagen dosage: 375 Iu 4 Times/week. Patient was hospitalized.

4635270-8 | Meningitis Cryptococcal
Patient was taking Adagen (View Usage). Patient had the following side effects: meningitis cryptococcal on Apr 01, 2005 from Additional patient health information: Male patient , child 7 years of age, was diagnosed with combined immunodeficiency and. Adagen dosage: 375 Iu 5 Times/week. Patient was hospitalized.

4620509-5 | Infection, Pneumonia Viral, Weight Decreased
Adverse event was reported on Mar 17, 2005 by a Male patient taking Adagen (View Usage) (Dosage: 1.5 Ml Twice Weekly Im) was diagnosed with enzyme abnormality and. Location: , child 12 years of age, After Adagen was administered, patient had the following side effects: infection (What is infection?), pneumonia viral, weight decreased.

4615747-1 | Infection, Pneumonia Viral, Weight Decreased
on Mar 03, 2005 Male patient from , child 12 years of age, was diagnosed with enzyme abnormality and was treated with Adagen (View Usage). Patient experienced the following unwanted or unexpected effects: infection (What is infection?), pneumonia viral, weight decreased. Adagen dosage: 1.5 Ml Twice Weekly Im.

4615745-8 | Antibody Test Positive, Haemolytic Anaemia, Immune System Disorder, Lung Disorder, Respiratory Tract Infection
on Mar 08, 2005 Female patient from , child 4 years of age, was diagnosed with combined immunodeficiency and was treated with Adagen (View Usage). Patient had the following side effects: antibody test positive, haemolytic anaemia, immune system disorder, lung disorder, respiratory tract infection. Adagen dosage: . During the same period patient was treated with HYDROCORTISOINE (View Hydrocortisoine Review and Hydrocortisoine Label ), NAPROSYN (View Naprosyn Review and Naprosyn Label ), SYNTHROID (View Synthroid Review and Synthroid Label ). Patient was hospitalized.

4603724-6 | Burkitt's Lymphoma, Central Nervous System Lymphoma
Patient was taking Adagen (View Usage). After Adagen was administered, patient had the following side effects: burkitt's lymphoma, central nervous system lymphoma on Feb 22, 2005 from Additional patient health information: Male patient , child 11 years of age, was diagnosed with combined immunodeficiency and. Adagen dosage: 500 Units Im 2x/weekly. Patient was hospitalized.

4598382-3 | Antibody Test Positive, Haemolytic Anaemia, Respiratory Tract Infection
Adverse event was reported on Feb 15, 2005 by a Female patient taking Adagen (View Usage) (Dosage: ) was diagnosed with combined immunodeficiency and. Location: , child 4 years of age, Patient experienced the following unwanted or unexpected effects: antibody test positive, haemolytic anaemia, respiratory tract infection.

4598379-3 | Infection, Pneumonia Viral, Weight Decreased
on Feb 15, 2005 Male patient from , child 12 years of age, was diagnosed with enzyme abnormality and was treated with Adagen (View Usage). Patient had the following side effects: infection (What is infection?), pneumonia viral, weight decreased. Adagen dosage: 1.5 Ml Twice Weekly Im.

4587168-1 | Central Nervous System Lymphoma
on Feb 08, 2005 Male patient from , child 11 years of age, was diagnosed with combined immunodeficiency and was treated with Adagen (View Usage). After Adagen was administered, patient had the following side effects: central nervous system lymphoma. Adagen dosage: . Patient was hospitalized.

4587167-X | Autoimmune Disorder, False Positive Laboratory Result, Haemolytic Anaemia, Immune System Disorder, Lung Disorder, Respiratory Tract Infection
Patient was taking Adagen (View Usage). Patient experienced the following unwanted or unexpected effects: autoimmune disorder, false positive laboratory result, haemolytic anaemia, immune system disorder, lung disorder, respiratory tract infection on Jan 28, 2005 from Additional patient health information: Female patient , child 4 years of age, was diagnosed with combined immunodeficiency and. Adagen dosage: .

4587162-0 | Infection, Pneumonia Viral, Weight Decreased
Adverse event was reported on Feb 03, 2005 by a Male patient taking Adagen (View Usage) (Dosage: 1.5 Ml Twice Weekly Im) was diagnosed with enzyme abnormality and. Location: , child 12 years of age, Patient had the following side effects: infection (What is infection?), pneumonia viral, weight decreased.

4579727-7 | Infection
on Feb 03, 2005 Male patient from , child 12 years of age, was diagnosed with combined immunodeficiency and was treated with Adagen (View Usage). After Adagen was administered, patient had the following side effects: infection (What is infection?). Adagen dosage: 250 Iu Qweek Im. Patient was hospitalized.

4569209-0 | Infection, Pneumonia Viral, Weight Decreased
on Jan 11, 2005 Male patient from , child 12 years of age, was treated with Adagen (View Usage). Patient experienced the following unwanted or unexpected effects: infection (What is infection?), pneumonia viral, weight decreased. Adagen dosage: 1.5 Ml Twice Weekly Im.

4569206-5 | Autoimmune Disorder, Haemolytic Anaemia, Lung Disorder, Nasopharyngitis, Respiratory Tract Infection
Patient was taking Adagen (View Usage). Patient had the following side effects: autoimmune disorder, haemolytic anaemia, lung disorder, nasopharyngitis, respiratory tract infection on Jan 18, 2005 from Additional patient health information: Female patient , child 4 years of age, was diagnosed with immunodeficiency and. Adagen dosage: .